Skip to main content

Client News

AFYREN Begins New Phase of Industrial Strategy as First Plant AFYREN NEOXY Achieves Continuous Production

17th June 2025

MIG Capital Announces €50 Million in Series A Funding for Look Up

12th June 2025

Andera Partners increases international development of its Mezzanine Sponsorless business and announces two strategic appointments

12th June 2025

Abivax Announces Results of its June 6, 2025 Annual General Meeting

11th June 2025

Mallia Secures European Patent Covering sCD83 for Hair Growth and Wound Healing

11th June 2025

PL BioScience Strengthens Management Team with Appointment of Oliver Dick as Chief Technology Officer

11th June 2025

Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

10th June 2025

DEBRA Research Announces Grant Opportunity for Epidermolysis bullosa Invitation to Submit Proposals

10th June 2025

ViGeneron Rebrands as VeonGen Therapeutics and Announces FDA Rare Pediatric Disease Designation and Clinical Progress for Lead Gene Therapy VG801 in Stargardt Disease

5th June 2025

Lucentis® biosimilar FYB201/Ranivisio® (ranibizumab) approved in Brazil

5th June 2025